期刊文献+

奈韦拉平合成进展 被引量:1

Development in Synthesis of Nevirapine
下载PDF
导出
摘要 本文介绍了抗HIV新药奈韦拉平的合成路线研究进展,并评价了其优缺点。 Synthesis methods for new drug Nevirapine of HIV were reviewed and their advantages and disadvantages were described in this paper.
出处 《浙江化工》 CAS 2007年第5期15-16,共2页 Zhejiang Chemical Industry
关键词 奈韦拉平 合成 综述 Nevirapine synthesis review
  • 相关文献

参考文献14

  • 1涂国刚,李少华.非核苷类逆转录酶抑制剂奈韦拉平[J].中国临床药理学与治疗学,2003,8(6):604-607. 被引量:18
  • 2孟庆伟,曾伟,赖琼,李悦青,赵伟杰.奈韦拉平的合成[J].中国医药工业杂志,2006,37(1):5-7. 被引量:12
  • 3Schneider H,Christmann A.Process for the preparation of nevirapine (11 -cyclopropyl-5,11 -dihydro-4-methyl6H -dipyrido[3,2 -b:2',3' -e][1,4 -d iazepin] -6 -one)[P].DE:4403311,1995-04-20.
  • 4Hargrave K,Proudfoot J.5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection[P].US:5366972,1994-11-22.
  • 5Schneider H,Christmann A.Process for preparing nevirapine[P].US:5569760,1996-10-29.
  • 6Kelly T.Method for preparing alkyl-5,11-dihydro6h -dipyrido[3,2 -B:2',3' -E][1,4] diazepin -6 -ones[P].US:5532358,1996-07-02.
  • 7Boswell R,Gupton B.Method for making nevirapine[P].US:2004002603,2004-01-01.
  • 8Gharpure M,Bhawal B.An improved process for industrial manufacture of nevirapine[P].WO:2007010352,2007-01-25.
  • 9许青青,杨亦文.CAPIC的合成路线图解[J].中国医药工业杂志,2005,36(3):189-191. 被引量:2
  • 10Grozinger K,Hargrave K.Method for preparing 3-amino-2-chloro-4-alkylpyridines[P].US:5200522,1993-04-06.

二级参考文献75

  • 1[1]Hargrave KD, Proudfoot JR, Adams J, et al . 5.11-Dihydro-6H-dipyrido (3,2-B:2',3'-E)(1,4) diazepines and their use in the prevention or treatment of HIV infection[S]. US.Cl 514/220,5366972.1994.12
  • 2[2]Temesgen Z, Wright AJ. Antiretrovirals[J]. Mayo Clin Proc, 1999;74:1284-301
  • 3[3]Voelker R. New HIV drugs cast in supporting roles[J]. JAMA ,1996; 276:585-6
  • 4[4]Guay LA, Musoke P, Fleming T , et al. Intrapartum and neonatal single-dose nevirapine compared with zidovndine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial[J]. Lancet, 1999;354:795-802
  • 5[5]Marseille E, Kohn JG, Mmiro F, et al. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa[J].Lancet,1999;354:803-9
  • 6[6]Schneider H, Christmann A. Process for preparing nevirapine[S]. US.Cl.540/495. 5569760.1996.10
  • 7[7]Kohlstaedt LA, Wang J, Friedman JM, et al. Crystal structure at 3.5? resolution of HIV-1 reverse transicriptase complexed with an inhibitor[J]. Science,1992;256:1783-90
  • 8[8]Wu JC, Warren TC, Adams J, et al. A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site [J]. Biochemistry, 1991;30:2022-6
  • 9[9]Palladino DEH, Hopkins JL, Ingraham RH, et al. High-performance liquid chromatography and photoaffinity crosslinking to explore the binding environment of nevirapine to reverse transeriptase of human immunodeficiency virs type-1[J]. J Chromatogr A, 1994;676:99-112
  • 10[10]Hannongbua S, Prasithichokekul S, Pungpo P. Conformational analysis of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, based on quantum mechanical calculations[J]. J Comput Alided Mol Des, 2002;15:997-1004

共引文献31

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部